High volume hemofiltration in septic shock;Hemofiltración de alto volumen en shock séptico

Medicina Intensiva

Volumn 34, Issue 5, 2010, Pages 345-352

  Romero, C M ^a,b   Downey, P ^c,d   Hernandez G ^c,d  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d Rheumatology Service   (Chile)

Author keywords

Hemofiltration; High volume hemofiltration; Kidney failure acute; Sepsis; Shock septic

Indexed keywords

ANIMAL EXPERIMENT; HEMOFILTRATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; SEPTIC SHOCK; SHORT SURVEY;

ANIMALS; HEMOFILTRATION; HUMANS; SHOCK, SEPTIC;

EID: 77953618666     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2009.10.001     Document Type: Short Survey

References (81)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United State: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B. CUB-Réa Network. Current epidemiology of septic shock. The CUB-Réa Network. Am J Respir Crit Care Med 2003, 168:165-172.
3. Silva E., Pedro M.de A., Sogayar A.C., Mohovic T., Silva C.L., Janiszewski M., et al. Brazilian sepsis epidemiological study (BASES study). Crit Care 2004, 8:251-260.
4. Dougnac A., Mercado M., Cornejo R., Cariaga M., Hernández G., Andresen M., et al. Prevalencia de sepsis grave en las unidades de cuidado intensivo. Primer estudio nacional multicéntrico. Rev Méd Chile 2007, 135:620-630.
5. Otero R.M., Nguyen H.B., Huang D.T., Gaieski D.F., Goyal M., Gunnerson K.J., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings. Chest 2006, 130:1579-1595.
6. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
7. Rivers E.P., Ahrens T. Improving outcomes for severe sepsis and septic shock: Tools for early identification of at-risk patients and treatment protocol implementation. Crit Care Clin 2008, 24:S1-S47.
8. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
9. Annane D., Bellissante E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
10. Nimah M., Brilli R.J. Coagulation dysfunction in sepsis and multiple organ system failure. Crit Care Clin 2003, 19:441-458.
11. Pinsky M.R. Phatophysiology of sepsis and multiple organ failure: Pro versus anti-inflammatory aspects. Contrib Nephrol 2004, 144:31-43.
12. Pinsky M.R. Sepsis and multiple organ failure. Contrib Nephrol 2007, 156:47-63.
13. Hoste E.A., Lameire N.H., Vanholder R.C., Benoit D.D., Decruyenaere J.M., Colardyn F.A. Acute renal failure in patients with sepsis in a surgical ICU: Predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 2003, 14:1022-1030.
14. Brun-Buisson C., Meshaka P., Pinton P., Vallet B. EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004, 30:580-588.
15. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123.
16. Joannidis M., Metnitz P.G.H. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 2005, 21:239-249.
17. Honoré PM, Jamez J, Wauthier M. Very high volume hemofiltration: A comprehensive review. Proceedings from the International Simposium on Critical Care Nephrology (ISCCN). Melbourne, Australia, Australasian Medical Pub Co, 2001.
18. Honoré PM, Joannes-Boyau O, Kotulak T. Report of the working party on high volume hemofiltration including definitions and classification. Proc 2nd Czech Conference on Critical Care Nephrology, Pardubice, Czech Republic, 2007.
19. Honoré P.M., Jamez J., Wauthier M., Lee P.A., Dugernier T., Pirenne B., et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587.
20. Joannes-Boyau O., Rapaport S., Bazin R., Fleureau C., Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004, 50:102-109.
21. Ratanarat R., Brendolan A., Piccinni P., Dan M., Salvatori G., Ricci Z. Pulse high-volume haemofiltration for treatment of severe sepsis: Effects on hemodynamics and survival. Crit Care 2005, 9:R294-R302.
22. Piccinni P., Dan M., Barbacini S., Carraro R., Lieta E., Marafon S., et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006, 32:80-86.
23. Herrera-Gutiérrez M.E., Seller-Pérez G., Lebrón-Gallardo M., Muñoz-Bono J., Banderas-Bravo E., Cordón-López A. Early hemodynamic improvement is a pronostic marker in patients treated with continuous CVVHDF for acute renal failure. ASAIO J 2006, 52:670-676.
24. Coraim F.J., Coraim H.P., Ebermann R., Stellwag F.M. Acute respiratory failure after cardiac surgery: Clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 1986, 14:714-718.
25. Goldfarb S., Golper T.A. Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994, 5:228-232.
26. Hoffmann J.N., Hartl W.H., Deppisch R., Faist E., Jochum M., Inthorn D. Hemofiltration in human sepsis. Evidence for elimination of immunomodulatory sunstances. Kidney Int 1995, 48:1563-1570.
27. Ronco C., Tetta C., Lupi A., Galloni E., Bettini M.C., Sereni L., et al. Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 1995, 23:99-107.
28. Gasche Y., Pascual M., Suter P.M., Favre H., Chevrolet J.C., Schifferli J.A. Complement depletion during hemofiltration with polyacrylonitrile membranes. Nephrol Dial Transplant 1996, 11:117-119.
29. Sánchez-Izquierdo Riera J.A., Pérez Vela J.L., Lozano Quintana M.J., Alted López E., Ortuño de Solo B., Ambros Checa A. Cytokines clearance during venovenous hemofiltrataion in the trauma patients. Am J Kidney Dis 1997, 30:483-488.
30. Kellum J.A., Johnson J.P., Kramer D., Palevsky P., Brady J.J., Pinsky M.R. Diffusive vs convective therapy. Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26:1995-2000.
31. De Vriese A.S., Vanholder R.C., Pascual M., Lameire N.H., Colardyn F.A. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?. Intensive Care Med 1999, 25:903-910.
32. García-Fernández N., Lavilla F.J., Rocha E., Purroy A. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy. J Nephrol 2000, 13:282-289.
33. Mariano F., Tetta C., Guida G.E., Triolo G., Camussi G. Hemofiltration reduces the priming activity on neutrophil chemiluminescence in septic patients. Kidney Int 2001, 60:1598-1605.
34. Bouman C.S., Van Olden R.W., Stoutenbeek C.P. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 1998, 16:261-268.
35. Clark W.R., Hamburger R.J., Lysaght M.J. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int 1999, 56:2005-2015.
36. Kellum J.A., Dishart M.K. Effect of hemofiltration filter adsorption on circuling IL-6 levels in septic rats. Crit Care 2002, 6:429-433.
37. Morgera S., Slowinski T., Melzer C., Sobottke V., Vargas-Hein O., Volk T., et al. Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004, 43:444-453.
38. Morgera S., Haase M., Kuss T., Vargas-Hein O., Zuckermann-Becker H., Melzer C., et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006, 34:2099-2104.
39. Morgera S., Haase M., Rocktäschel J., Böhler T., Von Heymann C., Vargas-Hein O., et al. High permeability haemofiltration improves peripheral blood mononuclear cell prolipheration in septic patients with acute renal failure. Nephrol Dial Transplant 2003, 18:2570-2576.
40. Morgera S., Haase M., Rocktäschel J., Böhler T., Vargas-Hein O., Melzer C., et al. Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure. Nephron Clin Pract 2003, 94:c75-c80.
41. Venkataraman R., Subramanian S., Kellum J.A. Extracorporeal blood purification in severe sepsis. Crit Care 2003, 7:139-145.
42. Bellomo R., Honoré P.M., Matson J., Ronco C., Winchester J. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs 2005, 28:450-458.
43. Bouchard J., Khosla N., Mehta R.L. Emerging therapies for extracorporeal support. Nephron Physiol 2008, 109:85-91.
44. Ronco C., Tetta C., Mariano F., Wratten M.L., Bonello M., Bordoni V., et al. Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 2003, 27:792-801.
45. Honoré P., Matson J.R. Extracorporeal removal for sepsis: Acting at the tissue level-the beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004, 32:896-897.
46. Di Carlo J.V., Alexander S.R. Hemofiltration for cytokine-driven illness: The mediator delivery hypothesis. Int J Artif Organs 2005, 28:777-786.
47. Heering P., Morgera S., Schmitz F.J., Schmitz G., Willers R., Schultheiss H.P., et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997, 23:288-296.
48. Tetta C., Bellomo R., Ronco C. Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: Recent new trends. Artif Organs 2003, 27:202-213.
49. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
50. Polderman K.H., Girbes A.R. Drug intervention trials in sepsis: Divergent results. Lancet 2004, 363:1721-1723.
51. Tetta C., Bellomo R., Kellum J., Ricci Z., Pohlmeiere R., Passlick-Deetjen J., et al. High volume hemofiltration in critically ill patients: Why, when and how?. Contrib Nephrol 2004, 144:362-375.
52. Honoré P.M., Joannes-Boyau O. High volume hemofiltration (HVHF) in sepsis: A comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Artif Organs 2004, 27:1077-1082.
53. Grootendorst A.F., Van Bommel E.F., Vander Hoven B., Van Leengoed L.A., Van Osta L.A. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992, 18:235-240.
54. Grootendorst A.F., Van Bommel E.F., Vander Hoven B. High volume hemofiltration improves haemodynamics in endotoxin induced shock in the pigs. J Crit Care 1992, 7:67-75.
55. Grootendorst A.F., Van Bommel E.F., Vander Hoven B., Van Leengoed L.A., Van Zande A.R., Huygens H.J. Infusion of ultrafiltrate from endotoxemic pigs depressed myocardial performance in normal pigs. J Crit Care 1993, 8:61-69.
56. Grootendorst A.F., Van Bommel E.F., Van Leengoed L.A., Nabuurs M., Boumans C.S., Groenefeld A.B.J. High volume hemofiltration improves haemodynamics and survival of pigs exposed to gut ischemia reperfusion. Shock 1994, 2:72-78.
57. Lee P.A., Matson J.R., Pryor R.W., Hinshaw L.B. Continous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicaemia in immature swine. Crit Care Med 1993, 21:914-924.
58. Nagashima M., Shin'oka T., Nollert G., Shum-Tim D., Hickey P.R., Roth S.J., et al. High volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary disfunction in neonatal lambs after deep hypothermic circulatory arrest. Circulation 1998, 98:II378-II384.
59. Yekebas E.F., Treede H., Knoefel W.T., Blochle C., Fink E., Isbicki J.R. Influence of zero balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 1999, 229:514-522.
60. Bellomo R., Kellum J.A., Gandhi C.R., Pinsky M.R., Ondulik B. The effect of intensive plasma water exchange by haemofiltration on haemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000, 161:1429-1436.
61. Ullrich R., Roeder G., Lorber C., Quezado Z.M., Kneifel W., Gasser H., et al. Continuous venovenous haemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology 2001, 98:428-436.
62. Rogiers P., Zhang H., Pauwels D., Vincet J.L. Comparison of polyacrylonitrile (AN69) and polysulfone membrane doing hemofiltration in canine endotoxic shock. Crit Care Med 2003, 31:1219-1225.
63. Wang H., Zhang Z.H., Yan X.W., Li W.Q., Ji D.X., Quan Z.F., et al. Amelioration of haemodynamics and oxygen metabolism by continuous veno venous hemofiltration in experimental pancreatitis. World J Gastroenterol 2005, 11:127-131.
64. Rogiers P., Zhang H., Smail N., Pauwels D., Vincent J.L. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999, 27:1848-1855.
65. Bellomo R., Kellum J.A., Gandhi C.R., Pinsky M.R. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000, 161:1429-1436.
66. Yekebas E.F., Eisenberger C.F., Ohnesorge H., Saalmüller A., Elsner H.A., Engelhardt M., et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 2001, 29:1423-1430.
67. Ronco C., Bellomo R., Homel P., Brendolan A., Dan M., Piccinni P., et al. Effects of different doses in continuous veno-nenous hemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000, 356:26-30.
68. Cole L., Bellomo R., Hart G., Journois D., Davenport P., Tipping P., et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002, 30:100-106.
69. Payen D., Mateo J., Cavaillon J.M., Fraisse F., Floriot C., Vicaut E., et al. Impact of cotinuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med 2009, 37:803-810.
70. Oudemans-Van Straaten H.M., Bosman R.J., Van der Spoel J.I., Zandstra D.F. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis. Intensive Care Med 1999, 25:814-821.
71. Cole L., Bellomo R., Journois D., Davenport P., Baldwin I., Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001, 27:978-986.
72. Jiang H.L., Xue W.J., Li D.Q., Yin A.P., Xin X., Li C.M., et al. Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005, 11:4815-4821.
73. Boussekey N., Chiche A., Faure K., Devos P., Guery B., D'Escrivan T., et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008, 34:1646-1653.
74. Brendolan A., D'Intini V., Ricci Z., Bonello M., Ratanarat R., Salvatori G., et al. Pulse high volume hemofiltration. Int J Artif Organs 2004, 27:398-403.
75. Ratanarat R., Brendolan A., Ricci Z., Salvatori G., Nalesso F., De Cal M., et al. Pulse high-volume hemofiltration in critically ill patients: A new approach for patients with septic shock. Semin Dial 2006, 19:69-74.
76. Romero C., Downey P., Espinoza M., Luengo C., Mercado Dougnac A., et al. Hemofiltración de alto volumen en el manejo hemodinámico del shock séptico severo: un reporte preliminar. Rev Chil Med Intensiva 2006, 21:14-18.
77. Hernández G., Bruhn A., Romero C., Larrondo F.J., De la Fuente R., Castillo L., et al. Management of septic shock with norepinephrine-based haemodinamic algorithm. Resuscitation 2005, 66:63-69.
78. Cornejo R., Downey P., Castro R., Romero C., Regueira T., Vega J., et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006, 32:713-722.
79. Bruhn A., Godoy C., Ruiz C., Izquierdo G., López R., Andresen M., et al. Effects of high volume hemofiltration (HFAV) on sublingual microcirculation in septic shock (SS) patients. Intensive Care Med 2009, (Suppl 1):S32.
80. Romero C., Cornejo R., Tobar E., Gálvez R., Llanos O.P., Castro J. Reanimación protocolizada del shock séptico. Rev Hosp Clín Univ Chile 2008, 19:127-141.
81. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212. Acute Dialysis Quality Initiative workgroup.